These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11951795)

  • 1. Present status of endovascular brachytherapy in peripheral arteries.
    Pokrajac B; Minar E; Kirisits C; Pötter R
    Herz; 2002 Feb; 27(1):56-61. PubMed ID: 11951795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study.
    Pokrajac B; Pötter R; Wolfram RM; Budinsky AC; Kirisits C; Lileg B; Mendel H; Sabeti S; Schmid R; Minar E
    Radiother Oncol; 2005 Jan; 74(1):3-9. PubMed ID: 15683661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease.
    Pokrajac B; Kirisits C; Schmid R; Schillinger M; Berger D; Peer K; Tripuraneni P; Pötter R; Minar E
    Cardiovasc Revasc Med; 2009; 10(3):162-5. PubMed ID: 19595397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study.
    Pokrajac B; Schmid R; Kirisits C; Mock U; Fellner C; Wambersie A; Pötter R; Minar E
    Radiother Oncol; 2002 Apr; 63(1):97-102. PubMed ID: 12065109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study.
    Minar E; Pokrajac B; Ahmadi R; Maca T; Seitz W; Stümpflen A; Pötter R; Ehringer H
    Radiology; 1998 Jul; 208(1):173-9. PubMed ID: 9646810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis.
    Pokrajac B; Pötter R; Maca T; Fellner C; Mittlböck M; Ahmadi R; Seitz W; Minar E
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):923-31. PubMed ID: 11072147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five year follow-up after brachytherapy for restenosis in peripheral arteries.
    Liermann DD; Bauernsachs R; Schopohl B; Böttcher HD
    Semin Interv Cardiol; 1997 Jun; 2(2):133-7. PubMed ID: 9546994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular brachytherapy in the femoropopliteal segment using 192Ir and 188Re.
    Wohlgemuth WA; Leissner G; Wengenmair H; Bohndorf K; Kirchhof K
    Cardiovasc Intervent Radiol; 2008; 31(4):698-708. PubMed ID: 18185955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis.
    Ho KJ; Devlin PM; Madenci AL; Semel ME; Gravereaux EC; Nguyen LL; Belkin M; Menard MT
    J Vasc Surg; 2017 Mar; 65(3):734-743. PubMed ID: 27986482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial.
    Wolfram RM; Budinsky AC; Pokrajac B; Pötter R; Minar E
    Radiology; 2005 Jul; 236(1):343-51. PubMed ID: 15987985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results.
    Wolfram RM; Pokrajac B; Ahmadi R; Fellner C; Gyöngyösi M; Haumer M; Bucek R; Pötter R; Minar E
    Radiology; 2001 Sep; 220(3):724-9. PubMed ID: 11526274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endovascular Ir-192 HDR brachytherapy for avoidance of intimal hyperplasia in peripheral vessels after PTA and stent implantation. A 6-year experience].
    Böttcher HD; Schopohl B
    Strahlenther Onkol; 1998 Mar; 174(3):115-20. PubMed ID: 9524619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up--prospective randomized study.
    Wolfram RM; Budinsky AC; Pokrajac B; Potter R; Minar E
    Radiology; 2006 Sep; 240(3):878-84. PubMed ID: 16926331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary observations on the need for control angiography after peripheral endovascular brachytherapy using a centering balloon.
    Hofmann WJ; Kopp M; Kofler B; Ugurluoglu A; Kogelnik D; Magometschnigg H
    J Endovasc Ther; 2002 Apr; 9(2):241-5. PubMed ID: 12010109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience.
    Schopohl B; Leirmann D; Pohlit LJ; Heyd R; Strassmann G; Bauersachs R; Schulte-Huermann D; Rahl CG; Manegold KH; Kollath J; Bottcher HD
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):835-40. PubMed ID: 8960510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries.
    Bonvini R; Baumgartner I; Do DD; Alerci M; Segatto JM; Tutta P; Jäger K; Aschwanden M; Schneider E; Amann-Vesti B; Greiner R; Mahler F; Gallino A
    J Am Coll Cardiol; 2003 Feb; 41(3):409-12. PubMed ID: 12575967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions.
    Zehnder T; von Briel C; Baumgartner I; Triller J; Greiner R; Mahler F; Do DD
    J Endovasc Ther; 2003 Apr; 10(2):304-11. PubMed ID: 12877614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular brachytherapy in peripheral arteries.
    Minar E; Pokrajac B; Budinsky A; Pötter R
    Vasa; 2003 Feb; 32(1):3-9. PubMed ID: 12677757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries. An update.
    Liermann D; Kirchner J; Bauernsachs R; Schopohl B; Böttcher HD
    Herz; 1998 Sep; 23(6):394-400. PubMed ID: 9816526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Required treatment margin for coronary endovascular brachytherapy with iridium-192 seed ribbon.
    Giap H
    Cardiovasc Radiat Med; 2002; 3(1):49-55. PubMed ID: 12479916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.